However, in the anti-tumor process, CD8+T cells experience long-term chronic inflammation stimulation, resulting in high expression of co-inhibitory molecules and a suppressed cell function, leading to tumor immune escape (22), which ultimately impacts patient survival. The gene discussed is CD8A; the disease is neoplasm.